Allogene Therapeutics (ALLO) surges 60% premarket on ALPHA3 trial data breakthrough — April 14, 2026
Allogene Therapeutics (NASDAQ: ALLO) surged approximately 60% in premarket...
Allogene Therapeutics (NASDAQ: ALLO) surged approximately 60% in premarket...
Revolution Medicines (NASDAQ: RVMD) surged approximately 37% in premarket...
U.S. equities opened under pressure on Monday, April 13, 2026, with the S&P...
Segment Q1 2025 Actual Q1 2026 Consensus YoY Growth Total Net Revenue $15.06B...
Broadcom (NASDAQ: AVGO) surged 18.1% over the week ending April 11, 2026,...
The week of April 13–17, 2026 brings the most concentrated stretch of Q1...
Wall Street opened Friday, April 10, 2026, with a modest relief rally after the...
U.S. equities opened Friday at the S&P 500's session-open level of...
Delta Air Lines (NYSE: DAL) surged as much as 12% in premarket trading on...
U.S. equities surged at Wednesday's open after President Trump announced a...